 |
|
Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries
October 02, 2008WEST LAFAYETTE, Ind. - Purdue University researchers have developed a method of using nanoparticles to deliver treatments to injured brain and spinal cord cells.
A team led by Richard Borgens of the School of Veterinary Medicine's Center for Paralysis Research and Welden School of Biomedical Engineering coated silica nanoparticles with a polymer to target and repair injured guinea pig spinal cords. That research is being published in the October edition of the journal Small.
The team then used the coated nanoparticles to deliver both the polymer and hydralazine to cells with secondary damage from a naturally produced toxin. That research was published in August by the journal Nanomedicine.
Borgens' group had previously shown benefits of the polymer polyethylene glycol, or PEG, to treat rats with brain injuries and dogs with spinal cord injuries. PEG specifically targets damaged cells and seals the injured area, reducing further damage. It also helps restore cell function, Borgens said.
In previous studies, PEG was mixed with saline and injected.
"Composition and concentration limited how much PEG we could get to the injury," he said.
"If you change the composition to make the PEG more potent, it produces ethylene glycol, the poison in antifreeze. If you change the concentration of PEG in another way, the solution becomes syrupy and difficult to inject."
So the team - which includes Youngnam Cho of the Center for Paralysis Research, Riyi Shi of the center and Weldon School, and Albena Ivanisevic of Weldon School and the Department of Chemistry - turned to silica nanoparticles.
"These particles are so tiny they can't be seen with a regular microscope. They are about the size of a large virus. So you can inject as many as you need. And they are safe inside bodies," Borgens said.
In the first study, the researchers coated the nanoparticles with PEG to treat guinea pig spinal cord injuries. The treated spinal cord cells showed improved physiological functioning.
In the second study, the researchers added both PEG and hydralazine, an antihypertension drug, to mesoporous silica nanoparticles. These nanoparticles have pores that can hold the drug, which is later delivered to the damaged cells. The hydralazine was added to fight off secondary damage to cells that occurs after the initial injury.
"When cells are injured, they produce natural toxins," Borgens said. "Acrolein is the most poisonous of these toxins. It's an industrial hazard for which hydralazine is an antidote."
Borgens and his team introduced acrolein into cells and then treated the cells with different combinations of hydralazine and/or PEG delivered by the mesoporous silica nanoparticles.
They found that the treatment restored disrupted cell function caused by acrolein.
The team concluded that the use of nanoparticles to deliver both PEG and hydralazine increased the effectiveness of earlier PEG-only treatment by controlling and concentrating release of the drug and the polymer, producing a dual treatment and prolonging the treatment's duration.
The goal of Borgens' research is to improve the quality of life of those who have suffered head or spinal cord injuries.
"All ambulances should have PEG on board," he said. "It can probably save thousands of people from more severe head and spinal damage."
Financial support for the studies came from the state of Indiana and an endowment from Mari Hulman George.
The researchers now are testing the PEG/hydralazine treatment on rats with brain injuries. By the end of the year, they hope to test the treatment on naturally injured paraplegic dogs.
Purdue University
Borgens' group had previously shown benefits of the polymer polyethylene glycol, or PEG, to treat rats with brain injuries and dogs with spinal cord injuries. PEG specifically targets damaged cells and seals the injured area, reducing further damage. It also helps restore cell function, Borgens said.
In previous studies, PEG was mixed with saline and injected.
"Composition and concentration limited how much PEG we could get to the injury," he said.
"If you change the composition to make the PEG more potent, it produces ethylene glycol, the poison in antifreeze. If you change the concentration of PEG in another way, the solution becomes syrupy and difficult to inject."
So the team - which includes Youngnam Cho of the Center for Paralysis Research, Riyi Shi of the center and Weldon School, and Albena Ivanisevic of Weldon School and the Department of Chemistry - turned to silica nanoparticles.
"These particles are so tiny they can't be seen with a regular microscope. They are about the size of a large virus. So you can inject as many as you need. And they are safe inside bodies," Borgens said.
In the first study, the researchers coated the nanoparticles with PEG to treat guinea pig spinal cord injuries. The treated spinal cord cells showed improved physiological functioning.
In the second study, the researchers added both PEG and hydralazine, an antihypertension drug, to mesoporous silica nanoparticles. These nanoparticles have pores that can hold the drug, which is later delivered to the damaged cells. The hydralazine was added to fight off secondary damage to cells that occurs after the initial injury.
"When cells are injured, they produce natural toxins," Borgens said. "Acrolein is the most poisonous of these toxins. It's an industrial hazard for which hydralazine is an antidote."
Borgens and his team introduced acrolein into cells and then treated the cells with different combinations of hydralazine and/or PEG delivered by the mesoporous silica nanoparticles.
They found that the treatment restored disrupted cell function caused by acrolein.
The team concluded that the use of nanoparticles to deliver both PEG and hydralazine increased the effectiveness of earlier PEG-only treatment by controlling and concentrating release of the drug and the polymer, producing a dual treatment and prolonging the treatment's duration.
The goal of Borgens' research is to improve the quality of life of those who have suffered head or spinal cord injuries.
"All ambulances should have PEG on board," he said. "It can probably save thousands of people from more severe head and spinal damage."
Financial support for the studies came from the state of Indiana and an endowment from Mari Hulman George.
The researchers now are testing the PEG/hydralazine treatment on rats with brain injuries. By the end of the year, they hope to test the treatment on naturally injured paraplegic dogs.
Purdue University
Nanoparticles Current Events and Nanoparticles News RSSThe gold standard: Biodesign Institute researchers use nanoparticles to make 3-D DNA nanotubes
Arizona State University researchers Hao Yan and Yan Liu imagine and assemble intricate structures on a scale almost unfathomably small. Their medium is the double-helical DNA molecule, a versatile building material offering near limitless construction potential.
Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.
No quick or easy technological fix for climate change, researchers say
Global warming, some have argued, can be reversed with a large-scale "geoengineering" fix, such as having a giant blimp spray liquefied sulfur dioxide in the stratosphere or building tens of millions of chemical filter systems in the atmosphere to filter out carbon dioxide.
Rivers are carbon processors, not inert pipelines
Microorganisms in rivers and streams play a crucial role in the global carbon cycle that has not previously been considered.
Stanford blood scanner detects even faint indicators of cancer
A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.
Researchers shed new light on catalyzed reactions
Rice University scientists on the hunt for a better way to clean up the stubborn pollutant TCE have created a method that lets them watch molecules break down on the surface of a catalyst as individual chemical bonds are formed and broken.
Nontoxic nanoparticle can deliver and track drugs
A nontoxic nanoparticle developed by Penn State researchers is proving to be an all-around effective delivery system for both therapeutic drugs and the fluorescent dyes that can track their delivery.
Conference report highlights new research into drug delivery to treat eye disease
Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
Nanoparticles trigger cell death?
Nanoparticles that are one milliard of a metre in size are widely used, for example, in cosmetics and food packaging materials.
UD researchers show that plants can accumulate nanoparticles in tissues
Researchers at the University of Delaware have provided what is believed to be the first experimental evidence that plants can take up nanoparticles and accumulate them in their tissues.
More Nanoparticles Current Events and Nanoparticles News Articles
 | Safety of Nanoparticles: From Manufacturing to Medical Applications (Nanostructure Science and Technology) In spite of the potential use of nanomaterials as tissue engineering devices, implants, biosensors, drug delivery devices, etc., there has yet to be a compilation of the risks associated with the in vivo use of nanomaterials. There are numerous and well-known risks because of the size of nanoparticles. For example, nanoparticles can cross cell membranes and enter the cytoplasm undetected. The... |
 | Nanoparticle Technology Handbook Nanoparticle technology, which handles the preparation, processing, application and characterisation of nanoparticles, is a new and revolutionary technology. It becomes the core of nanotechnology as an extension of the conventional Fine Particle / Powder Technology. Nanoparticle technology plays an important role in the implementation of nanotechnology in many engineering and industrial fields... |
 | Metal Nanoparticles: Synthesis Characterization & Applications by Daniel L. Feldheim Offers the latest research on the synthesis, characterization, and applications of nanoparticle structural, optical, and electronic... |
 | AC Electrokinetic: Colloids and Nanoparticles (Microtechnologies and Microsystems) by Hywel Morgan, Nicolas G. Green Biologists, physicists and engineers are working together to make ever-smaller devices capable of studying the properties of tiny biological particles. Using nano-electrodes, encapsulated in a device with dimensions of a few hundred millionths of a meter, it is now possible to manipulate and trap single nano-scale biological particles such as a virus. The precisely controlled electric fields... |
 | Nanoparticles: From Theory to Application An introduction to the science of nanoparticles, from fundamental principles to their use in novel applications. As a basis for understanding nanoparticle behavior, the book first outlines the principles of quantum size behavior, nanoparticles architecture, formation of semiconductor and metal nanoparticles. It then goes on to describe the chemical syntheses of nanoparticles with defined... |
 | Metallic Nanoparticles, Volume 5 (Handbook of Metal Physics) Metallic nanoparticles display fascinating properties that are quite different from those of individual atoms, surfaces or bulk rmaterials. They are a focus of interest for fundamental science and, because of their huge potential in nanotechnology, they are the subject of intense research effort in a range of disciplines. Applications, or potential applications, are diverse and interdisciplinary.... |
 | Nanoparticle Technology for Drug Delivery (Drugs and the Pharmaceutical Sciences) Nanoparticles, products of nanotechnology, are of increasing interest to the pharmaceutical community. They can increase drug solubility, enhance bioavailability, allow tissue targeting, offer decreased side-effects, and improve therapeutic efficacy. Presenting the most pertinent and practical issues in the manufacturing and biological application of nanoparticles, this source presents... |
 | Nanopathology: The Health Impact of Nanoparticles by Antonietta M. Gatti, Stefano Montanari Enormous funds are currently being invested in nanotechnology, yet very little is known about how its products and by-products can interfere with organisms, both end-users and people involved in their manufacture. Similar scenarios are already widely known in the history of science, such as the exploitation of radioactivity or the controversial issue of genetically modified organisms. As... |
 | Nanoparticles: New Research This book provides leading edge research from around the globe in the field of nanoparticles which is a small particle with at least one dimension less than 100 nm. A nanoparticle is an amorphous or semicrystalline zero dimensional (0D) nano structure with at least one dimension between 10 and 100nm and a relatively large ( Y 15 per cent) size dispersion. Nanoparticle research is currently an... |
 | Nanoparticles and Occupational Health (Journal of Nanoparticle Research, 9) Nanotechnology is rapidly invading many aspects of modern society - from science, research and engineering to industrial and commercial applications and, inevitably, to man and his environment. One of the biggest challenges, therefore, is managing environmental, health and safety risks of nanomaterials. Yet, the information necessary to assess their long term effects is scarce. Systematic... |
| © 2009 BrightSurf.com |